'No systemic issue' insists GSK amid yet more corruption allegations
This article was originally published in Scrip
Executive Summary
Jordan and Lebanon have been added to the growing list of countries where GlaxoSmithKline is investigating allegations of bribery, the pharma giant has admitted in a statement.